ABSTRACT
Introduction Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option in elderly patients with aortic stenosis. However, numerous challenges need to be addressed in order to further improve the outcome of this distinct cohort, one of which is the risk of cerebrovascular events (CVE) related to TAVI. Individual stroke risk cumulates in aged patients with severe aortic stenosis resulting in an annual event rate of up to 4.5%.1,2 e prevalence of CVEs is mainly related to patient age and comorbidities, reaching up to 15% in healthy octogenarians, and exceeding this number in aged patients with aortic stenosis.3 ese numbers characterize the high baseline stroke risk of patients eligible for TAVI.
